BLOOD DISPOSITIONS OF MITOMYCIN-C AND A LIPOPHILIC PRODRUG AFTER INTRAMUSCULAR AND INTRAVENOUS ADMINISTRATION IN LIPOSOMES AND O/W EMULSION

被引：0
|
作者：
SASAKI, H
KAKUTANI, T
HASHIDA, M
KIMURA, T
SEZAKI, H
机构：
[1] KYOTO UNIV, FAC PHARMACEUT SCI, YOSHIDA SHIMOADACHI CHO, SAKYO KU, KYOTO 606, JAPAN
[2] NAGASAKI UNIV, FAC PHARMACEUT SCI, NAGASAKI 852, JAPAN
[3] OKAYAMA UNIV, FAC PHARMACEUT SCI, OKAYAMA 700, JAPAN
来源：
CHEMICAL & PHARMACEUTICAL BULLETIN | 1985年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：2968 / 2973
页数：6
相关论文
共 10 条
  • [1] ABSORPTION CHARACTERISTICS OF THE LIPOPHILIC PRODRUG OF MITOMYCIN-C FROM INJECTED LIPOSOMES OR AN EMULSION
    SASAKI, H
    KAKUTANI, T
    HASHIDA, M
    SEZAKI, H
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (07) : 461 - 465
  • [2] CHARACTERIZATION OF LIPOSOMES AND AN EMULSION CONTAINING MITOMYCIN-C OR LIPOPHILIC MITOMYCIN-C PRODRUGS
    SASAKI, H
    KAKUTANI, T
    HASHIDA, M
    SEZAKI, H
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (12) : 1166 - 1170
  • [3] ANTITUMOR-ACTIVITY OF LIPOPHILIC PRODRUGS OF MITOMYCIN-C ENTRAPPED IN LIPOSOME OR O/W EMULSION
    SASAKI, H
    TAKAKURA, Y
    HASHIDA, M
    KIMURA, T
    SEZAKI, H
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1984, 7 (02): : 120 - 130
  • [4] DEVELOPMENT OF A NOVEL POLYMERIC PRODRUG OF MITOMYCIN-C, MITOMYCIN-C-DEXTRAN CONJUGATE WITH ANIONIC CHARGE .2. DISPOSITION AND PHARMACOKINETICS FOLLOWING INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATION
    TAKAKURA, Y
    ATSUMI, R
    HASHIDA, M
    SEZAKI, H
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 37 (1-2) : 145 - 154
  • [5] LIPOSOMAL SUSTAINED-RELEASE DELIVERY SYSTEMS FOR INTRAVENOUS-INJECTION .2. DESIGN OF LIPOSOME CARRIERS AND BLOOD DISPOSITION OF LIPOPHILIC MITOMYCIN-C PRODRUG-BEARING LIPOSOMES
    TOKUNAGA, Y
    IWASA, T
    FUJISAKI, J
    SAWAI, S
    KAGAYAMA, A
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1988, 36 (09) : 3557 - 3564
  • [6] LIPOSOMAL SUSTAINED-RELEASE DELIVERY SYSTEMS FOR INTRAVENOUS-INJECTION .3. ANTITUMOR-ACTIVITY OF LIPOPHILIC MITOMYCIN-C PRODRUG-BEARING LIPOSOMES
    TOKUNAGA, Y
    IWASA, T
    FUJISAKI, J
    SAWAI, S
    KAGAYAMA, A
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1988, 36 (09) : 3565 - 3573
  • [7] Pharmacokinetics of vancomycin after intravenous administration of a w/o/w emulsion to rats
    Okochi, H
    Nakano, M
    DRUG DELIVERY, 1997, 4 (03) : 167 - 172
  • [8] THE PHARMACOKINETIC PLASMA PROFILE OF MITOMYCIN-C, MEASURED AFTER SEQUENTIAL INTERMITTENT INTRAVENOUS ADMINISTRATION
    LANKELMA, J
    STUURMAN, M
    VANHOOGENHUIJZE, J
    VANBOCHOVE, A
    VERMORKEN, JB
    VERWEIJ, J
    PINEDO, HM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02): : 175 - 180
  • [9] Biodistribution and pharmacokinetics of O-palmitoyl tilisolol, a lipophilic prodrug of tilisolol, after intravenous administration in rats
    Kawakami, S
    Ohshima, N
    Hirayama, R
    Hirai, M
    Kitahara, T
    Sakaeda, T
    Mukai, T
    Nishida, K
    Nakamura, J
    Nakashima, M
    Sasaki, H
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (08) : 1072 - 1076
  • [10] SYSTEMIC BLOOD-LEVELS AFTER INTRA-ARTERIAL ADMINISTRATION OF MICROENCAPSULATED MITOMYCIN-C IN CANCER-PATIENTS
    MILANO, G
    BOUBLIL, JL
    BRUNETON, JN
    BOURRY, J
    RENEE, N
    THYSS, A
    ROUX, P
    NAMER, M
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1985, 10 (03) : 197 - 201
1